Marthe Charles

Marthe Charles

Auto-generated profile, based on publicly available information

Marthe Charles

Division of Medical Microbiology and Infection Control, Department of Pathology and Laboratory Medicine, Vancouver General Hospital , Vancouver Coastal Health, Vancouver, British Columbia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
DGDavid Goldfarb
David Goldfarb
PTPeter Tilley
Peter Tilley
GAGhada N. Al-Rawahi
Ghada N. Al-Rawahi
JSJocelyn A. Srigley
Jocelyn A. Srigley
GFGeoffrey Ford
Geoffrey Ford
LHLinda M. N. Hoang
Linda M. N. Hoang
We assessed the performance, stability, and user acceptability of swab-independent self-collected saliva and saline mouth rinse/gargle sample types for the molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults and school-aged children. Outpatients who had recently been diagnosed with COVID-19 or were presenting with suspected COVID-19 were asked to have a nasopharyngeal (NP) swab collected and provide at least one self-collected sample type.

1 March 2021 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
EEEric J. Eckbo
Eric J. Eckbo
KLKerstin Locher
Kerstin Locher
MCMelissa Caza
Melissa Caza
LLLisa Li
Lisa Li
VLValery Lavergne
Valery Lavergne
MCMarthe Charles
Marthe Charles

1 June 2021 in American Journal of Infection Control
Verified
Journal Article
Closed access
EEEric J. Eckbo
Eric J. Eckbo
TWTitus Wong
Titus Wong
ABAmrita Bharat
Amrita Bharat
MCMary Cameron-Lane
Mary Cameron-Lane
LHLinda Hoang
Linda Hoang
MCMarthe Charles
Marthe Charles

2 May 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NGNick P G Gauthier
Nick P G Gauthier
WCWilson Chan
Wilson Chan
KLKerstin Locher
Kerstin Locher
DSDuane Smailus
Duane Smailus
RCRobin Coope
Robin Coope
AMAmee R Manges
Amee R Manges
Current molecular diagnostics are limited in the number and type of detectable pathogens. Metagenomic next generation sequencing (mNGS) is an emerging, and increasingly feasible, pathogen-agnostic diagnostic approach. Translational barriers prohibit the widespread adoption of this technology in clinical laboratories. We validate an end-to-end mNGS assay for detection of respiratory viruses. Our assay is optimized to reduce turnaround time, lower cost-per-sample, increase throughput, and deploy secure and actionable bioinformatic results. We validated our assay using residual nasopharyngeal swab specimens from Vancouver General Hospital (n = 359), RT-PCR-positive, or negative for Influenza, SARS-CoV-2, and RSV. We quantified sample stability, assay precision, the effect of background nucleic acid levels, and analytical limits of detection. Diagnostic performance metrics were estimated. We report that our mNGS assay is highly precise, semi-quantitative, with analytical limits of detection ranging from 103-104 copies/mL. Our assay is highly specific (100%) and sensitive (61.9% Overall: 86.8%; RT-PCR Ct < 30). Multiplexing capabilities enable processing of up to 55-specimens simultaneously on an Oxford Nanopore GridION device, with results reported within 12-hours. This study outlines the diagnostic performance and feasibility of mNGS for respiratory viral diagnostics, infection control, and public health surveillance. We addressed translational barriers to widespread mNGS adoption.

13 March 2024 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
CDClaudine Desruisseaux
Claudine Desruisseaux
CBConor Broderick
Conor Broderick
VLValéry Lavergne
Valéry Lavergne
KSKim Sy
Kim Sy
DGDuang-Jai Garcia
Duang-Jai Garcia
MCMarthe K. Charles
Marthe K. Charles
This study aimed to validate Metasystems’ automated acid-fast bacilli (AFB) smear microscopy scanning and deep-learning-based image analysis module (Neon Metafer) with assistance on respiratory and pleural samples, compared to conventional manual fluorescence microscopy (MM). Analytical parameters were assessed first, followed by a retrospective validation study. In all, 320 archived auramine-O-stained slides selected non-consecutively [85 originally reported as AFB-smear-positive, 235 AFB-smear-negative slides; with an overall mycobacterial culture positivity rate of 24.1% (77/320)] underwent whole-slide imaging and were analyzed by the Metafer Neon AFB Module (version 4.3.130) using a predetermined probability threshold (PT) for AFB detection of 96%. Digital slides were then examined by a trained reviewer blinded to previous AFB smear and culture results, for the final interpretation of assisted digital microscopy (a-DM). Paired results from both microscopic methods were compared to mycobacterial culture. A scanning failure rate of 10.6% (34/320) was observed, leaving 286 slides for analysis. After discrepant analysis, concordance, positive and negative agreements were 95.5% (95%CI, 92.4%–97.6%), 96.2% (95%CI, 89.2%–99.2%), and 95.2% (95%CI, 91.3%–97.7%), respectively. Using mycobacterial culture as reference standard, a-DM and MM had comparable sensitivities: 90.7% (95%CI, 81.7%–96.2%) versus 92.0% (95%CI, 83.4%–97.0%) ( P -value = 1.00); while their specificities differed 91.9% (95%CI, 87.4%–95.2%) versus 95.7% (95%CI, 92.1%–98.0%), respectively ( P -value = 0.03). Using a PT of 96%, MetaSystems’ platform shows acceptable performance. With a national laboratory staff shortage and a local low mycobacterial infection rate, this instrument when combined with culture, can reliably triage-negative AFB-smear respiratory slides and identify positive slides requiring manual confirmation and semi-quantification. IMPORTANCE: This manuscript presents a full validation of MetaSystems’ automated acid-fast bacilli (AFB) smear microscopy scanning and deep-learning-based image analysis module using a probability threshold of 96% including accuracy, precision studies, and evaluation of limit of AFB detection on respiratory samples when the technology is used with assistance. This study is complementary to the conversation started by Tomasello et al. on the use of image analysis artificial intelligence software in routine mycobacterial diagnostic activities within the context of high-throughput laboratories with low incidence of tuberculosis.

14 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DGDavid Goldfarb
David Goldfarb
PTPeter Tilley
Peter Tilley
GAGhada N. Al-Rawahi
Ghada N. Al-Rawahi
JSJocelyn A Srigley
Jocelyn A Srigley
GFGeoffrey Ford
Geoffrey Ford
LHLinda M. N. Hoang
Linda M. N. Hoang
Background: We assessed the performance, stability, and user acceptability of swab-independent self-collected saliva and saline mouth rinse/gargle sample types for the molecular detection of SARS-CoV-2 in adults and school-aged children. Methods: Outpatients who had recently been diagnosed with COVID-19 or were presenting with suspected COVID-19 were asked to have a nasopharyngeal swab collected and provide at least one self-collected sample type. A portion of participants were also asked about sample acceptability. Samples underwent molecular testing using multiple assays. Saline mouth rinse/gargle and saliva samples were tested daily at time zero, day one, and day 2 to assess nucleic acid stability at room temperature. Results: 50 participants (aged 4 to 71 years) were included; of these, 40 had at least one positive sample and were included in the primary sample yield analysis. Saline mouth rinse/gargle samples had a sensitivity of 98% (39/40) while saliva samples had a sensitivity of 79% (26/33). Both saline mouth rinse/gargle and saliva samples showed stable viral RNA detection after 2 days of room temperature storage. Mouth rinse/gargle samples had the highest (mean 4.9) and HCW-collected NP swabs had the lowest acceptability scores (mean 3.1). Conclusion: Saline mouth rinse/gargle samples demonstrated the highest combined user acceptability ratings and analytical performance when compared with saliva and HCW collected NP swabs. This sample type is a promising swab-independent option, particularly for outpatient self-collection in adults and school aged children.